Cytek Biosciences, Inc.

CTKB · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$98,716$167,299$296,601$364,618
Short-Term Investments$179,145$95,111$44,548$0
Receivables$60,588$56,120$50,875$29,633
Inventory$43,893$60,877$48,154$32,171
Other Curr. Assets$14,104$12,653$13,842$5,311
Total Curr. Assets$396,446$392,060$454,020$431,733
Property Plant & Equip (Net)$28,130$29,258$27,565$5,851
Goodwill$16,663$16,183$10,144$10,144
Intangibles$20,128$23,084$4,331$4,739
Long-Term Investments$1,600$1,600$0$0
Tax Assets$33,374$30,487$20,459$9,173
Other NC Assets$3,159$1,785$2,957$1,665
Total NC Assets$103,054$102,397$65,456$31,572
Other Assets$0$0$0$0
Total Assets$499,500$494,457$519,476$463,305
Liabilities
Payables$5,529$3,032$4,805$3,034
Short-Term Debt$8,414$3,009$3,511$0
Tax Payable$3,559$1,297$1,667$3,879
Deferred Revenue$26,610$22,695$14,541$8,099
Other Curr. Liab.$23,551$26,193$24,516$18,169
Total Curr. Liab.$67,663$56,226$49,040$33,181
LT Debt$8,602$11,127$14,583$0
Deferred Rev, NC$16,098$15,132$13,124$9,790
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$11,400$18,908$17,183$14,949
Total NC Liab.$36,100$45,167$44,890$24,739
Other Liabilities$0$0$0$0
Cap. Leases$11,308$11,923$15,243$0
Total Liabilities$103,763$101,393$93,930$57,920
Equity
Pref Stock$0$0$0$0
Common Stock$129$131$135$126
Retained Earnings-$35,199-$29,178-$17,030-$19,606
AOCI$16-$1,275-$697$897
Other Equity$430,791$423,386$442,887$423,625
Total Equity$395,737$393,064$425,295$405,042
Supplemental Information
Minority Interest$0$0$251$343
Total Liab. & Tot. Equity$499,500$494,457$519,476$463,305
Net Debt-$81,700-$153,163-$278,507-$364,618